Skip to content
MedsAcross

Medicine

Albuterol 0.83 mg/mL inhalation solution

Albuterol · Inhalation
Available on requestPrescription onlyUS FDAGeneric name

Albuterol 0.83 mg/mL inhalation solution is a generic prescription medicine for inhalation use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C…

Key facts

Active ingredient (INN)
Albuterol
Brand
Sold under the generic name
Strength
0.83 mg/mL
Dosage form
Inhalation solution
Route
Inhalation
Packs
30 pouches, 5 pouches, 6 pouches and 14 more
Manufacturers
Aurobindo PharmaIndiaSun Pharmaceutical IndustriesIndiaLuoxin Aurovitas Pharma (Chengdu)Proficient RxRemedyrepackPreferred PharmaceuticalsRedpharm Drug
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (59° and 86°F). Storage PROTECT FROM LIGHT. Store in pouch until time of use.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
R03AC02 Albuterol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
17 October 2017
Identifiers
RxCUI 630208DailyMed set ID 5d62969b-2ad9-6cf0-e063-6394a90ac2f0, eafa5b05-d692-48e7-a413-30f847547eb2, 54172384-9726-4a11-901e-3fb8f1baccae +5NDC 67296-2338, 65862-858, 70518-4490 +5Application ANDA207857, ANDA206224

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
30 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 3 mL in 1 vial, single-dose65862-858-03Aurobindo PharmaIndia17 October 2017
5 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 3 mL in 1 vial, single-dose65862-858-25Aurobindo PharmaIndia17 October 2017
6 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 3 mL in 1 vial, single-dose65862-858-30Aurobindo PharmaIndia17 October 2017
12 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 3 mL in 1 vial, single-dose65862-858-60Aurobindo PharmaIndia17 October 2017
5 pouch in 1 carton / 5 vial in 1 pouch / 3 mL in 1 vial47335-703-49Sun Pharmaceutical IndustriesIndia11 June 2021
6 pouch in 1 carton / 5 vial in 1 pouch / 3 mL in 1 vial47335-703-52Sun Pharmaceutical IndustriesIndia11 June 2021
12 pouch in 1 carton / 5 vial in 1 pouch / 3 mL in 1 vial47335-703-54Sun Pharmaceutical IndustriesIndia11 June 2021
30 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 3 mL in 1 vial, single-dose81894-104-02Luoxin Aurovitas Pharma (Chengdu)17 October 2017
5 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 3 mL in 1 vial, single-dose81894-104-25Luoxin Aurovitas Pharma (Chengdu)17 October 2017
6 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 3 mL in 1 vial, single-dose81894-104-30Luoxin Aurovitas Pharma (Chengdu)17 October 2017
12 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 3 mL in 1 vial, single-dose81894-104-60Luoxin Aurovitas Pharma (Chengdu)17 October 2017
5 pouch in 1 carton / 5 vial in 1 pouch / 3 mL in 1 vial70518-3560-1Remedyrepack19 October 2022
5 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 3 mL in 1 vial, single-dose70518-4490-0Remedyrepack3 October 2025
5 pouch in 1 carton / 5 vial in 1 pouch / 3 mL in 1 vial68788-8492-2Preferred Pharmaceuticals24 July 2023
5 pouch in 1 carton / 5 vial in 1 pouch / 3 mL in 1 vial71205-641-25Proficient Rx25 February 2022
6 pouch in 1 carton / 5 vial in 1 pouch / 3 mL in 1 vial71205-641-30Proficient Rx8 April 2025
6 pouch in 1 carton / 5 vial in 1 pouch / 3 mL in 1 vial67296-2338-9Redpharm Drug11 June 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 1 May 1981Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Albuterol

Clinical summary

Albuterol is a beta2-adrenergic agonist indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. MedsAcross supplies Albuterol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Albuterol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Albuterol 0.83 mg/mL inhalation solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.